 AIM ImmunoTech Inc NYSE:AIM has announced that safety data on its drug Ampligen was recently presented at the Eighth European Scientific Working Group on Influenza ESWI virtual conference in Salzburg, Austria. The conference, which ran from December 4-7, 2021, also included research on coronavirus COVID-19 and respiratory syncytial virus. 